$0.00
(+0.00%
) Quote details
USD
( +0.00%
At Close (As of Jan 1, 1970)
$4.47B
Market Cap
36.52
P/E Ratio
0.98
EPS
$38.00
52 Week High
$7.62
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Indivior PLC is a leading biopharmaceutical company headquartered in North Chesterfield, Virginia, focused on developing innovative treatments for opioid dependence and related disorders. Known for its pioneering work with buprenorphine-based therapies, Indivior aims to improve patient outcomes and tackle the complexities associated with opioid use disorder. The company demonstrates a strong commitment to public health through substantial investments in research and development, reinforcing its position as a transformative leader in addiction treatment. With a comprehensive product portfolio and a dedicated patient-centric approach, Indivior is well-prepared to address the evolving challenges within the healthcare landscape.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
BITF
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
SMR
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
EOSE
GOOG
LUV
TSM
BMY
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
BITF
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
SMR
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
EOSE
GOOG
LUV
TSM
BMY